CAT
Caterpillar Inc.
CAT has a slight edge over EPAC overall, supported by stronger modeled upside and stronger fundamentals.
EPAC
Enerpac Tool Group Corp.
EPAC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
EPAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
EPAC's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
EPAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $39.29 | — |
| Current | 23x | $39.29 | — |
| Cheap | 24x | $40.96 | +4.2% |
| Fair | 33x | $56.28 | +43% |
| Expensive | 96x | $164 | +318% |
Historical ranges are pointers, not guarantees.
EPAC has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over EPAC on the outlook, with more favorable profitability expectations.
EPAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for EPAC, but weaker profitability.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
EPAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | +19% |
| Q3 2026 | $1.72 | +1.2% |
| Q2 2026 | $1.76 | +8% |
| Q1 2026 | $1.59 | -5.9% |
| Q4 2025 | $1.66 | +1.2% |
| Q3 2025 | $1.70 | +9% |
| Q2 2025 | $1.63 | +7.9% |
| Q1 2025 | $1.69 | +34% |
| Q4 2024 | $1.64 | +62% |
EPAC has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over EPAC on profitability, with a higher operating margin.
EPAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $185.7M | +11% |
| Q2 2026 | $167.6M | +5.6% |
| Q1 2026 | $154.8M | +6.4% |
| Q4 2025 | $144.2M | -0.7% |
| Q3 2025 | $167.5M | +5.5% |
| Q2 2025 | $158.7M | +5.5% |
| Q1 2025 | $145.5M | +5.1% |
| Q4 2024 | $145.2M | +2.3% |
EPAC's revenue has picked up after three years of holding roughly level: $186M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -5.3 points |
| Q2 2026 | 25% | +4.7 points |
| Q1 2026 | 16% | -5 points |
| Q4 2025 | 20% | -1.7 points |
| Q3 2025 | 24% | +4.9 points |
| Q2 2025 | 20% | -2.2 points |
| Q1 2025 | 21% | -0.1 points |
| Q4 2024 | 21% | +1.3 points |
EPAC's operating margin was 18% last quarter, down 5.3 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
EPAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $59.6M | +14% |
| Q2 2026 | $36.7M | +4.7% |
| Q1 2026 | $10M | +456% |
| Q4 2025 | $13.3M | +376% |
| Q3 2025 | $52.3M | +38% |
| Q2 2025 | $35.1M | +23% |
| Q1 2025 | $1.8M | -85% |
| Q4 2024 | $2.8M | +$11M |
EPAC has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
EPAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +632K shares |
| 1 year | -4.2% | -2.3M shares |
| 3 years | -8.6% | -4.9M shares |
| 5 years | -14% | -8.2M shares |
| Available history | -14% | -8.4M shares |
EPAC has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $34,000 |
| Q2 2026 | $15.2M |
| Q1 2026 | $51M |
| Q4 2025 | $14.9M |
| Q3 2025 | $40.1M |
| Q2 2025 | $14M |
| Q1 2025 | $10.2M |
| Q4 2024 | $4.4M |
EPAC spent $81M buying back its own shares over the past year, up 18% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over EPAC on leverage, with a lower net debt burden relative to earnings.
EPAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.5x | Very low |
EPAC's net debt is less than a year of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
EPAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 65.8 | Neutral |
EPAC's weekly RSI is 59 (neutral) and its Stochastic is 66 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
EPAC PE vs Industrials Sector
| Metric | EPAC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 5.1% below |
| PE % | 12 | 58 | 46 pts below |
EPAC has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
EPAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.0 | 6.2% above |
| 20 week MA | $36.4 | 7.9% above |
| 50 week MA | $37.1 | 6% above |
| 100 week MA | $39.4 | 0.4% below |
| 200 week MA | $36.1 | 8.8% above |
EPAC has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over EPAC on returns for 2026, with the stronger performance.
EPAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.3 | $21.9 | -17% |
| 2021 | $21.9 | $20.0 | -8.5% |
| 2022 | $20.0 | $25.3 | +26% |
| 2023 | $25.3 | $31.1 | +23% |
| 2024 | $31.1 | $41.4 | +33% |
| 2025 | $41.4 | $40.3 | -2.5% |
| 2026 YTD | $40.3 | $39.3 | -2.6% |
EPAC has finished lower in three of the last six years. It's down 2.6% so far in 2026.